SecBot SecBot

OPRX

OptimizeRx Corp
Nasdaq· Services-Business Services, NEC· Inc. NV· CIK 0001448431 Software & IT
$9.07 −0.08 (−0.87%)
Oct 26 4:00 PM ET · prev $9.15
Market cap
$171.0M
Micro cap
Consensus
Buy
92% Buy or better · 12 analysts
Median target
$11.00
+21% · range $11.00–18.00
Next earnings
Nov 10
in 14 days · EPS est. $0.16
1 year
−56.6%
from $20.88 · Oct 27
30 days
+16.1%
from $7.81
52-week range
$4.54–21.04
−57% from high · low Jun 23
Avg volume 20D
156.4K
shares / day
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BULLISH 3 reports · 90 days
Balance 0 bearish · 1 bullish · 1 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 10, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBEARISH

    Q2 2026: 13 added (0 new), 24 trimmed or exited.

  • AnalystsBULLISH

    11 of 12 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.246 → $0.162 over 90 days. 0 up, 1 down in 30 days.

  • TrendUPTREND

    12% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 19.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.TRIM445,382$2.5M
GEODE CAPITAL MANAGEMENT, LLCTRIM207,345$1.2M
VANGUARD PORTFOLIO MANAGEMENT LLCTRIM169,538$969.8K
MARSHALL WACE, LLPDOUBLED162,186$927.7K
MORGAN STANLEYDOUBLED156,314$894.1K
GOLDMAN SACHS GROUP INCTRIM105,037$600.8K
Quantinno Capital Management LPDOUBLED99,124$567.0K
Trexquant Investment LPTRIM89,666$512.9K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts
Buy 92% rate it Buy or better
Strong Buy4Buy7Hold1Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +21%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Sep 29, 2026B. Riley Securities
MAINTAIN
MAINTAINBuy
Aug 14, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform
May 13, 2026Lake Street
MAINTAIN
MAINTAINBuy
May 13, 2026B. Riley Securities
MAINTAIN
MAINTAINBuy
May 13, 2026Stephens & Co.
MAINTAIN
MAINTAINEqual-Weight
May 13, 2026Stifel
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 1, 2026
D'Silva Andrew J.
Chief Business Officer
TAX W/H$3.5K
Sep 1, 2026
D'Silva Andrew J.
Chief Business Officer
TAX W/H$11.3K
Aug 21, 2026
Silvestro Stephen L
Chief Executive Officer
TAX W/H$13.4K
Aug 21, 2026
Merrell Brendan W.
CHIEF OPERATING OFFICER
TAX W/H$7.9K
Aug 21, 2026
Stelmakh Edward
Chief Finance & Strat Officer
TAX W/H$10.6K
Aug 21, 2026
D'Silva Andrew J.
Chief Business Officer
TAX W/H$9.6K
Aug 21, 2026
Odence-Ford Marion
Chief Legal & Admin Officer
TAX W/H$11.8K
Aug 20, 2026
Silvestro Stephen L
Chief Executive Officer
AWARD79,200 sh

Earnings setup

Estimates
Nov 10
reports in 14 days
$0.16
EPS estimate, this quarter
−34%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.16$0.10–$0.22-4.7%$21.2M
Next Q🔒 Fresh data, subscribers only
Current FY$0.88$0.72–$0.99-1.6%$96.2M
Next FY🔒 Fresh data, subscribers only
Reddit
Recent posts
All social signals and their track records

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 SEC
Royce & Associates LP filed an amended Schedule 13G for OptimizeRx Corp, disclosing beneficial ownership of 1,315,057…
SC 13G/A — Impact 3/10
Oct 1, 2026 Insider
D'Silva Andrew J. surrendered for taxes 414 shares
Chief Business Officer @ $8.39 ($3.5K)
Sep 22, 2026 SEC
In Q2 2026, OptimizeRx saw a mixed institutional cluster: 13 buyers (led by Marshall Wace, Morgan Stanley, and…
INST-CLUSTER — Impact 3/10
Sep 8, 2026 Other
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX),
Sep 1, 2026 Insider
D'Silva Andrew J. surrendered for taxes 1,432 shares
Chief Business Officer @ $7.86 ($11.3K)
Aug 21, 2026 Insider
Silvestro Stephen L surrendered for taxes 1,737 shares
Chief Executive Officer @ $7.71 ($13.4K)
Aug 12, 2026 SEC
OptimizeRx reported Q2 2026 revenue of $20.5M and EPS of $0.14, beating consensus estimates of $20.2M and $0.11…
PRESS-RELEASE — Impact 6/10
Jun 30, 2026 Inst.
BlackRock, Inc. — TRIM
445,382 shares ($2.5M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Sep 8, 2026
Press release
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology…
Aug 12, 2026
Press release
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
The Company Names Andy D’Silva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027
Aug 12, 2026
Earnings
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
– Q2 revenue totals $20.5 million – Q2 net loss and adjusted EBITDA of $(0.7) million and $4.9 million, respectively – Reaffirms fiscal year 2026…
Aug 12, 2026
Earnings date
OPRX Q2 2026 Earnings Scheduled — 2026-08-12
Aug 6, 2026
Earnings date
OPRX Q2 2026 Earnings Scheduled — 2026-08-06

SecBot reports

9 filings · 3 press releases · 2 bullish · 0 bearish · 3 mixed · 4 neutral
All OPRX filing & press-release reports (12)